Delivery Order SPE2DB22D2108-SPE2DB25FU4WV
- Not listed
- The Defense Logistics Agency awarded a $2,351.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with performance in Conshohocken, Pennsylvania and an ultimate completion date of June 27, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,039.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 10, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $9,699.77 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The work will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $47,038.50 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub for...
- The Defense Logistics Agency awarded a $4,685.90 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of M-M-R II vaccine vials. The contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,462.82 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $6,225.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,933.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. The delivery order represents a small-value transaction typical of routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with performance to be completed by September 11, 2025. The contract, which became effective on September 10, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,371.44 for M-M-R II vaccine vials, with an ultimate completion date of May 13, 2025. This firm fixed-price contract, awarded on May 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-competitive and will be performed at...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU4WVDelivery Order
The Defense Logistics Agency awarded a $55,042.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of June 25, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major healthcare solutions provider and pharmaceutical distributor for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across multiple therapeutic domains, with delivery orders typically employing firm fixed pricing structures ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.0k | 6/24/25 |